on Wednesday flagged promising late-phase demo results for its new Cagrilinitide weight problems treatment, since the Danish pharmaceutical big seeks a next-generation option to its blockbuster Wegovy fat-loss drug.This Web site is using a security assistance to protect itself from online attacks. The action you just performed triggered the securit